Lennox-Gastaut Syndrome (LGS)

Lennox-Gastaut Syndrome (LGS) is a rare but severe form of childhood epilepsy. It is characterized by multiple seizure types, cognitive impairment, and abnormal electroencephalogram (EEG) findings. Managing LGS is challenging due to its resistance to treatment, making early diagnosis crucial for improving quality of life.

PAEDIATRICSNEUROLOGY

Rishwin A R

2/23/20252 min read

person holding baby
person holding baby

Causes and Risk Factors

LGS can arise from various underlying conditions, but in some cases, the cause remains unknown. Common causes include:

  • Brain malformations – Structural abnormalities present at birth.

  • Genetic mutations – Some cases are linked to specific genetic syndromes.

  • Brain injuries – Trauma before or after birth, including perinatal asphyxia.

  • Infections – Central nervous system infections like meningitis or encephalitis.

  • Metabolic disorders – Rare metabolic conditions affecting brain function.

Symptoms

LGS presents with a combination of symptoms, primarily:

1. Multiple Seizure Types

  • Tonic seizures – Sudden muscle stiffening, often during sleep.

  • Atonic seizures – Sudden loss of muscle tone, leading to falls.

  • Atypical absence seizures – Brief staring spells with subtle movement changes.

  • Myoclonic seizures – Sudden, brief muscle jerks.

2. Cognitive and Behavioral Impairment

  • Intellectual disability or developmental delays.

  • Learning difficulties and memory problems.

  • Behavioral challenges like aggression, hyperactivity, or autistic traits.

3. EEG Abnormalities

  • Slow spike-and-wave patterns seen during wakefulness.

  • Paroxysmal fast activity during sleep.

Diagnosis

Diagnosing LGS involves a combination of clinical assessment and diagnostic tests:

  • Medical history and symptom evaluation

  • EEG monitoring – Identifies characteristic electrical activity in the brain.

  • Brain imaging (MRI/CT scans) – Helps detect structural abnormalities.

  • Genetic testing – Identifies possible hereditary links.

Treatment Options

LGS is notoriously difficult to manage, requiring a multimodal approach:

1. Medications

  • Anti-seizure drugs – Valproate, Clobazam, Lamotrigine, Rufinamide, and Topiramate.

  • Cannabidiol (CBD) – FDA-approved Epidiolex has shown promise.

  • Corticosteroids – Sometimes used for seizure control.

2. Dietary Therapies

  • Ketogenic diet – High-fat, low-carbohydrate diet that can reduce seizure frequency.

  • Modified Atkins diet – Less restrictive alternative with similar benefits.

3. Surgical Interventions

  • Corpus callosotomy – Cutting the connection between brain hemispheres to prevent seizure spread.

  • Vagus nerve stimulation (VNS) – Implantable device that sends electrical impulses to reduce seizures.

  • Deep brain stimulation (DBS) – Experimental but potentially beneficial in some cases.

Prognosis and Quality of Life

The long-term outlook for LGS varies widely. While seizures persist in most cases, early intervention can help improve daily functioning. Supportive therapies, including physical, occupational, and speech therapy, play a crucial role in enhancing quality of life.

Frequently Asked Questions (FAQs)

1. Is Lennox-Gastaut Syndrome genetic?

Not always. Some cases have a genetic component, but many are linked to brain injuries, infections, or unknown causes.

2. Can LGS be cured?

There is no cure, but treatment can help manage seizures and improve quality of life.

3. At what age does LGS typically appear?

LGS usually begins between ages 3 and 5 but can develop earlier or later.

4. Can children with LGS attend school?

Many children with LGS require special education programs tailored to their cognitive and behavioral needs.

5. How can families support a child with LGS?

A multidisciplinary approach, including medical treatment, therapy, and support groups, can significantly improve the child’s development and family coping mechanisms.